eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Boehringer Ingelheim Pharmaceuticals, Inc. - Comment

Boehringer Ingelheim Pharmaceuticals, Inc. - Comment

Document ID: FDA-2011-D-0432-0007
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: July 29 2011, at 12:00 AM Eastern Daylight Time
Date Posted: September 26 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: June 17 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: August 16 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80ecfd6f
View Document:  View as format xml

View Comment

See Attached

Attachments:

Boehringer Ingelheim Pharmaceuticals Inc Comment

Title:
Boehringer Ingelheim Pharmaceuticals Inc Comment

View Attachment: View as format pdf

Related Comments

    View All
Total: 7
Genentech, Inc. - Comment
Public Submission    Posted: 09/16/2011     ID: FDA-2011-D-0432-0003

Aug 16,2011 11:59 PM ET
Boehringer Ingelheim Pharmaceuticals, Inc. - Comment
Public Submission    Posted: 09/26/2011     ID: FDA-2011-D-0432-0007

Aug 16,2011 11:59 PM ET
AstraZeneca - Comment
Public Submission    Posted: 09/26/2011     ID: FDA-2011-D-0432-0008

Aug 16,2011 11:59 PM ET
PSI - Statisticians in the Pharmaceutical Industry - Comment
Public Submission    Posted: 09/26/2011     ID: FDA-2011-D-0432-0009

Aug 16,2011 11:59 PM ET
Pfizer, Inc. - Comment
Public Submission    Posted: 09/26/2011     ID: FDA-2011-D-0432-0010

Aug 16,2011 11:59 PM ET